Loading clinical trials...
Loading clinical trials...
Role of Cholecystokinin Receptor Blockade on the Tumor Microenvironment in Pancreatic Cancer
Conditions
Interventions
Gemcitabine
Nab paclitaxel
+2 more
Locations
1
United States
Lombardi Comprehensive Cancer Center, Georgetown University
Washington D.C., District of Columbia, United States
Start Date
January 31, 2024
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2027
Last Updated
May 23, 2025
NCT07409272
NCT05065801
NCT04605913
NCT06662006
NCT07296341
NCT06361888
Lead Sponsor
Georgetown University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions